There was no increased risk of infections with IV iron .
Gastrointestinal AEs were reduced with IV iron .
CONCLUSION Intravenous iron therapy is not associated with an increased risk of SAEs or infections .
Infusion reactions are more pronounced with IV iron
OBJECTIVE To amass all available evidence regarding the safety of intravenous ( IV ) iron preparations to provide a true balance of efficacy and safety .
The therapeutic equivalence of oral and intravenous iron in renal dialysis patients.
Oral and intravenous iron were compared in patients treated with renal dialysis by a cross-over trial . Intravenous iron was given over 2 weeks as an iron dextran ( equivalent to 100 mg elemental iron ) . Oral iron was given daily as ferrous sulphate ( equivalent to 100 mg elemental iron ) in a wax matrix tablet . Each treatment period lasted 26 weeks . There was no significant difference in therapeutic or unwanted effects between the treatments
There was no increased risk of infections with IV iron .
Gastrointestinal AEs were reduced with IV iron .
CONCLUSION Intravenous iron therapy is not associated with an increased risk of SAEs or infections .
Infusion reactions are more pronounced with IV iron
OBJECTIVE To amass all available evidence regarding the safety of intravenous ( IV ) iron preparations to provide a true balance of efficacy and safety .